Related Experiment Video
Updated: Jun 22, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Stemming out of a new PML era?
1MRC Toxicology Unit, Leicester, UK. ps90@le.ac.uk
Abstract:
The promyelocytic leukaemia protein PML is a growth and tumour suppressor inactivated in acute promyelocytic leukaemia (APL). Recent evidence indicates that PML plays a tumour-suppressive role in cancer of multiple histological origins. However, it is only very recently that PML growth-suppressive functions have been implicated in regulating physiological processes and tissue homoeostasis. In particular, it has been shown that PML is one of the key cell-cycle regulators controlling stem cell function in multiple tissues, from the blood to the brain. As a consequence, PML loss has an impact on tissue development and maintenance of stem cell pools. In addition, new data suggest that PML regulates self-renewal in cancer stem cells. Finally, the oncogenic fusion protein PML/RARalpha, contrary to the conventional view, appears to hijack growth-suppressive pathways to promote transformation of haematopoietic stem cells and to maintain the APL stem cell niche. Overall, these findings not only represent a change in paradigm in the field of PML/APL research, but also contribute to the understanding of fundamental mechanisms underlying stem cell function in vivo. The main objective of this review is to critically discuss the very recent literature on the role of PML in stem cells and tumour-initiating cells. Ultimately, it aims to propose new avenues of investigation.
Insights
The promyelocytic leukaemia protein (PML) is a tumor suppressor crucial for stem cell regulation in various tissues. Loss of PML impacts tissue development and stem cell pools, while its fusion protein drives cancer stem cell transformation.
Area of Science:
- Oncology
- Stem Cell Biology
- Molecular Biology
Background:
- The promyelocytic leukaemia protein (PML) is a known tumor suppressor, frequently inactivated in acute promyelocytic leukaemia (APL).
- Emerging evidence highlights PML's critical role in regulating physiological processes, tissue homeostasis, and stem cell function across diverse tissues.
- PML's function extends to controlling stem cell pools, tissue development, and self-renewal in both normal and cancer stem cells.
Purpose of the Study:
- To critically review recent literature on the role of PML in stem cells and tumor-initiating cells.
- To discuss the implications of PML's function in tissue homeostasis and cancer development.
- To propose novel research directions for PML in stem cell biology and oncology.
Main Methods:
- Literature review and critical analysis of recent studies.
- Synthesis of findings on PML's role in cell-cycle regulation and stem cell function.
- Examination of the oncogenic PML/RARalpha fusion protein's mechanism.
Main Results:
- PML is identified as a key regulator of stem cell function in multiple tissues, including blood and brain.
- PML loss affects tissue development and the maintenance of stem cell populations.
- The PML/RARalpha fusion protein hijacks PML's tumor-suppressive pathways to promote hematopoietic stem cell transformation and maintain the APL stem cell niche.
Conclusions:
- PML plays a fundamental role in regulating stem cell function and tissue homeostasis.
- PML inactivation and its aberrant fusion protein are central to APL pathogenesis by manipulating stem cell behavior.
- Understanding PML's multifaceted roles opens new avenues for cancer therapy and stem cell research.
More Related Videos
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
Methods of Documentation II: POMR
Lineage Commitment
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Mitral Valve Prolapse III: Nursing Management
Atypical Pneumonia